Application of Size and Maturation Functions to Population Pharmacokinetic Modeling of Pediatric Patients
Traditionally, dosage for pediatric patients has been optimized using simple weight-scaled methods, but these methods do not always meet the requirements of children. To overcome this discrepancy, population pharmacokinetic (PK) modeling of size and maturation functions has been proposed. The main o...
Main Authors: | Hyun-moon Back, Jong Bong Lee, Nayoung Han, Sungwoo Goo, Eben Jung, Junyeong Kim, Byungjeong Song, Sook Hee An, Jung Tae Kim, Sandy Jeong Rhie, Yoon Sun Ree, Jung-woo Chae, JaeWoo Kim, Hwi-yeol Yun |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/11/6/259 |
Similar Items
-
Pharmacocinétique de population chez les nouveau-nés et jeunes enfants : vers un modèle optimal pour la vancomycine et le phénobarbital
by: Marsot, Amélie
Published: (2012) -
Population Pharmacokinetic Modelling and Simulation to Determine the Optimal Dose of Nanoparticulated Sorafenib to the Reference Sorafenib
by: Ki Young Huh, et al.
Published: (2021-04-01) -
Pharmacometrics as an instrument of clinical pharmacology for optimization of drugs dosing regimens during pregnancy
by: Reshetko O.V., et al.
Published: (2014-03-01) -
Prophylactic Phenobarbital after Resolution of Neonatal Seizures
by: J Gordon Millichap
Published: (2008-11-01) -
Bioequivalence of two novel formulations of ivermectin 1% combined with fluazuron 12.5% for subcutaneous administration in cattle
by: Diego M. Robaina, et al.
Published: (2021-01-01)